Skip to main content

Drug, nutrition product sales power Abbott's revenue beat

Medical device maker Abbott Laboratories Inc beat quarterly sales estimates on Wednesday, benefiting from higher demand for its nutrition products and generic drug sales.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.